Cencora ThinkLive Cell and Gene Therapy Summit 2025 Summary

While cell and gene therapies (CGTs) are at the cutting edge of medicine, the obstacles to their widespread adoption—such as manufacturing, distribution, and patient access—are reminiscent of challenges faced with biologics years ago. The Cencora ThinkLive Cell and Gene Therapy Summit 2025 underscored a vital lesson: a steadfast commitment to the patient is paramount. This extends beyond affordability, encompassing the entire patient and caregiver experience. From developing adaptable support programs to creating patient-centric supply chains, the summit highlighted the necessity of a holistic and deeply personalized approach to commercialization.

Delve into the key takeaways from the summit by reading the complete article.